www.agingresearch.org Open in urlscan Pro
172.67.69.179  Public Scan

Form analysis
2 forms found in the DOM

GET https://www.agingresearch.org

<form class="search" action="https://www.agingresearch.org" method="get">
  <label for="site-keyword-search" class="screen-reader-text">Search:</label>
  <input id="site-keyword-search" type="text" name="s" placeholder="How can we help you?">
  <button type="submit">Go</button>
</form>

GET https://www.agingresearch.org

<form class="search" action="https://www.agingresearch.org" method="get">
  <label for="site-keyword-search-mobile" class="screen-reader-text">Search:</label>
  <input id="site-keyword-search-mobile" type="text" name="s" placeholder="How can we help you?">
  <button type="submit">Go</button>
</form>

Text Content

Skip to main content Return to top of page
Search: Go
 * What We Do
   * Advocacy
   * Aging & Health
   * Events & News
   * Our Initiatives
 * Who We Are
   * About Us
   * Staff
   * Board of Directors
   * Research Advisory Council
   * Coalitions
   * Financial Reports & Funding
   * Media Inquiries
 * Resources
   * Blog
   * Podcast
   * Videos
   * Documents
   * Newsletters

 * Ways to Get Involved
   * Individual Donors
   * Corporate Partners
 * Donate

Search Open navigation menu


The mission of Accelerate Cures/Treatments for All Dementias (ACT-AD) is to
support accelerating research and approval for transformational therapies to
modify the progression, or relieve symptoms, of all dementias.

ACT-AD brings together companies, advocacy groups, and researchers to interact
with the FDA outside of an IND to explore challenges and themes in ADRD clinical
development. ACT-AD also provides an overview of research priorities for the NIA
and coverage and reimbursement issues for new AD medical products. ACT-AD
translates complex regulatory issues to a wide range of stakeholders, including
patients and caregivers, to create more engagement on issues that would
otherwise be restricted to regulators and companies.


METHODS



Program objectives are:

 * To create a sense of urgency in support of bringing dementia products to
   market;
 * To obtain public and government recognition of dementia as a serious,
   life-threatening epidemic; and
 * To accelerate development of safe and effective disease-modifying and
   symptomatic therapies in dementia.


FDA/ACT-AD ALLIES ANNUAL MEETING



Every year the FDA and ACT-AD convene a roundtable meeting to explore the
current therapeutic and research landscape for Alzheimer’s disease and related
dementias. Sessions address pertinent issues in the field of dementia research
and include presentations from NIH/NIA funded investigators and private
industry.

The 17th Annual FDA/ACT-AD Allies meeting will be held November 7, 2024 at the
Marriott Marquis, 901 Massachusetts Ave., NW, Washington, DC. Attendance is by
invitation only.


PAST MEETING SUMMARIES




2023

The 16th Annual FDA/ACT-AD Allies Meeting was held November 16, 2023. Download a
PDF summary of the meeting.


2022

The 15th Annual FDA/ACT-AD Allies Meeting was held November 16, 2022. Download a
PDF summary of the meeting.


2019

The 12th Annual FDA/ACT-AD Allies Meeting was held November 2019. Download a PDF
summary of the meeting.


WEBINARS


WEBINAR: FINANCING THE CURE: EXPLORING THE ECOSYSTEM OF ALZHEIMER’S DISEASE
RESEARCH FUNDING

The Accelerate Cures/Treatments for All Dementias (ACT-AD) held a webinar on
July 13, 2021 for an in-depth…

more.


WEBINAR: RESEARCH AND CLINICAL DEVELOPMENT IN LEWY BODY DEMENTIA

On December 7, 2020, ACT-AD held a webinar on cutting-edge research on Lewy Body
dementia (LBD). The webinar…

more.


WEBINAR: THE EMERGING ANTIMICROBIAL PROTECTION HYPOTHESIS OF ALZHEIMER’S DISEASE

The Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) Coalition held
an educational webinar on April 18, 2019 on…

more.
See More Videos


TO LEARN MORE

To learn more about ACT-AD and the annual meeting, please
advocacy@agingresearch.org; and/or Beth Mathews-Bradshaw, Vice President of
Patient Engagement and Research, at bmbrad­shaw@agingresearch.org.

To learn more about sponsoring ACT-AD, please contact Sarah Delgado, Vice
President of Development, at sdelgado@agingresearch.org.



CONTACT US

Alliance for Aging Research
1700 K Street NW, Suite 740
Washington, DC 20006

202-293-2856

info@agingresearch.org


FOLLOW US

 * Facebook
 * Twitter
 * YouTube
 * Instagram


QUICK LINKS

 * Make a Donation
 * COVID-19 Information
 * Talk NERDY

© 2024 Alliance for Aging Research
 * Terms & Conditions
 * Accessibility
 * Website Design
 * Media Contact

 * What We Do
   * Advocacy
   * Aging & Health
   * Events & News
   * Our Initiatives
 * Who We Are
   * About Us
   * Staff
   * Board of Directors
   * Research Advisory Council
   * Coalitions
   * Financial Reports & Funding
   * Media Inquiries
 * Resources
   * Blog
   * Podcast
   * Videos
   * Documents
   * Newsletters

 * Ways to Get Involved
   * Individual Donors
   * Corporate Partners
 * Donate

Search: Go
Close menu